The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
1-(3-((pyrimidin-2-ylimino)methyl)-1H-indazol-6-yl)-3-(thiazol-2-yl)urea ID: ALA3786498
PubChem CID: 137174988
Max Phase: Preclinical
Molecular Formula: C16H12N8OS
Molecular Weight: 364.39
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: O=C(Nc1ccc2c(/C=N/c3ncccn3)n[nH]c2c1)Nc1nccs1
Standard InChI: InChI=1S/C16H12N8OS/c25-15(22-16-19-6-7-26-16)21-10-2-3-11-12(8-10)23-24-13(11)9-20-14-17-4-1-5-18-14/h1-9H,(H,23,24)(H2,19,21,22,25)/b20-9+
Standard InChI Key: BRWPEKHABDWLLK-AWQFTUOYSA-N
Molfile:
RDKit 2D
26 29 0 0 0 0 0 0 0 0999 V2000
-1.0028 1.5132 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.3155 0.7475 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.3155 -0.7475 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.0028 -1.5132 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.2917 0.7475 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.2917 -0.7475 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7138 -1.2033 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.5889 0.0182 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.7138 1.2033 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.1812 2.6271 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.6500 2.9355 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.1182 4.3614 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.5858 4.6718 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.0509 6.0979 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.0484 7.2137 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.5808 6.9034 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.1158 5.4773 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-3.6187 -1.4919 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-3.6267 -2.9927 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.9300 -3.7369 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-2.5905 -3.5979 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-4.9380 -5.2378 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-6.1544 -6.0936 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
-5.6956 -7.5217 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.1956 -7.5266 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.7274 -6.1016 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5 1 1 0
1 2 2 0
2 3 1 0
3 4 2 0
4 6 1 0
5 6 2 0
6 7 1 0
7 8 1 0
8 9 2 0
9 5 1 0
9 10 1 0
10 11 2 0
11 12 1 0
12 13 2 0
13 14 1 0
14 15 2 0
15 16 1 0
16 17 2 0
17 12 1 0
3 18 1 0
18 19 1 0
19 20 1 0
19 21 2 0
20 22 1 0
22 23 1 0
23 24 1 0
24 25 2 0
25 26 1 0
26 22 2 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 364.39Molecular Weight (Monoisotopic): 364.0855AlogP: 3.20#Rotatable Bonds: 4Polar Surface Area: 120.84Molecular Species: NEUTRALHBA: 7HBD: 3#RO5 Violations: ┄HBA (Lipinski): 9HBD (Lipinski): 3#RO5 Violations (Lipinski): ┄CX Acidic pKa: 7.32CX Basic pKa: 0.95CX LogP: 3.09CX LogD: 2.77Aromatic Rings: 4Heavy Atoms: 26QED Weighted: 0.48Np Likeness Score: -1.96
References 1. Yang Z, Fang Z, He W, Wang Z, Gan H, Tian Q, Guo K.. (2016) Identification of inhibitors for vascular endothelial growth factor receptor by using dynamic combinatorial chemistry., 26 (7): [PMID:26920800 ] [10.1016/j.bmcl.2016.02.063 ]